Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies

Virginia Protto, Maria Elena Marcocci, Mariya Timotey Miteva, Roberto Piacentini, Domenica Donatella Li Puma, Claudio Grassi, Anna Teresa Palamara, Giovanna De Chiara*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

Abstract

Herpes simplex virus-1 (HSV-1) is a ubiquitous DNA virus able to establish a life-long latent infection in host sensory ganglia. Following periodic reactivations, the neovirions usually target the site of primary infection causing recurrent diseases in susceptible individuals. However, reactivated HSV-1 may also reach the brain resulting in severe herpetic encephalitis or in asymptomatic infections. These have been reportedly linked to neurodegenerative disorders, such as Alzheimer's disease (AD), suggesting antiviral preventive or/therapeutic treatments as possible strategies to counteract AD onset and progression. Here, we provide an overview of the AD-like mechanisms driven by HSV-1-infection in neurons and discuss the ongoing trials repurposing anti-herpetic drugs to treat AD as well as preventive strategies aimed at blocking virus infection.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
Numero di pagine6
RivistaCurrent Opinion in Pharmacology
Volume63
DOI
Stato di pubblicazionePubblicato - 2022

Keywords

  • Alzheimer Disease
  • Brain
  • Herpes Simplex
  • Herpesvirus 1, Human
  • Humans
  • Neurons

Fingerprint

Entra nei temi di ricerca di 'Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies'. Insieme formano una fingerprint unica.

Cita questo